Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3- ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives

Antiviral Chemistry and Chemotherapy

Volumn 17, Issue 5, 2006, Pages 269-274

  Selvam, Periyasamy ^a   Murugesh, Narayanan ^b   Chandramohan, Markandavel ^c   Sidwell, Robert W ^d   Wandersee, Miles K ^d   Smee, Donald F ^d  

^a Arulmigy Kalasalingam Coll Pharmacy   (India)

^b MADURAI MEDICAL COLLEGE   (India)

^c Bharat Ratna Kamarajar Liver Hospital and Research Centre   (India)

^d UTAH STATE UNIVERSITY   (United States)

Author keywords

Antiviral; Influenza A; Influenza B; Isatin; Sulphadimidine

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; 5 BROMO 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; 5 CHLORO 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; 5 FLUORO 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; 5 METHYL 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; ANTIVIRUS AGENT; CYANOVIRIN N; ISATIN DERIVATIVE; N ACETYL 4 [(1,2 DIHYDRO 2 OXO 3H INDOL 3 YLIDENE)AMINO] N (4,6 DIMETHYL 2 PYRIMIDIN 2 YL)BENZENESULPHONAMIDE; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; KIDNEY CELL CULTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS REPLICATION;

EID: 33845462055     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020601700504     Document Type: Article

References (27)

1. Bauer DJ & Sadler PW (1960) The structure-activity relationships of the antiviral chemotherapeutic activity of isatin β-thiosemicarbazone. British Journal of Pharmacology and Chemotherapy 15:101-110.
2. Bauer DJ (1972) Thiosemicarbazones. In Chemotherapy of Virus Diseases Vol. 1, International Encyclopedia of Pharmacology; pp. 35-45. Oxford: Pergamon Press.
3. Cianci C & Krystal M (1998) Development of antivirals against influenza. Expert Opinion in Investigational Drugs 7:149-165.
4. Levinson W (1973) Inhibition of viruses, tumors and pathogenic organisms by isatin-β-thiosemicarbazones. In Selective inhibitors of viral functions; pp. 213. Edited by WA Carter. Cleveland: CRC Press.
5. Muller WEG, Maidhof A, Taschner H, & Zahn RK (1977) Virazole (1-β-D-ribofruranosyl-1,2,4-triazole-3-carboxamide), a cytostatic agent. Biochemical Pharmacology 26:1071-1075.
6. O'Keefe, BR, Smee DF., Turpin J, Saucedo C, Buckheit R & Boyd MR (2003) The virucidal protein cyanovirin-N displays potent anti-influenza activity mediated through interactions with viral hemagglutinin. Antimicrobial Agents and Chemotherapy 47:2518-2525.
7. Pandeya SN, Sriram D, De Clercq E, Pannecouque C & Witvrouw M (1998) Anti-HIV activity of some Mannich bases of isatin derivatives. Indian Journal of Pharmaceutical Science 60:207-212.
8. Pandeya SN, Yogeeswari P, Sriram D, De Clercq E, Pannecouque C & Witvrouw M (1999a) Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives. Chemotherapy 45:192-196.
9. Pandeya SN, Sriram D, Nath G & De Clercq E (1999b) Synthesis and antimicrobial activity of Schiff and Mannich of isatin and its derivatives with pyrimidine. Farmaco 54:624-628.
10. Pandeya SN, Sriram D, Nath G & De Clercq E (1999c) Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl] thiosemicarbazide. European Journal of Pharmaceutical Science 9:25-31.
11. Pandeya SN, Sriram D, Nath G & De Clercq E (1999d) Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff Mannich bases of isatin derivatives with 3-amino-2-methylmercaptoquinazolin-4(3H)-one. Pharmaceutica Acta Helvetica 74:11-17.
12. Pandeya SN, Sriram D, Nath G & De Clercq E (2000a) Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole. Arzneimittelforschung 50:55-59.
13. Pandeya SN, Sriram D, Nath G & De Clercq E (2000b) Synthesis, antibacterial, antifungal and anti-HIV activities of Norfloxacin Mannich bases. European Journal of Medicinal Chemistry 35:249-255.
14. Pauwels R, De Clercq E, Desmyter J, Balzarini J, Goubau P, Herdewijn P, Vandeputte M & Vanderbaeghe H (1987) Sensitive and rapid assay on MT- 4 cells for the detection of antiviral compounds against the AIDS virus. Journal of Virological Methods 16:171-185.
15. Popp FD (1969) Synthesis of potential antineoplastic agents. XX. Compounds related to the 3-o-nitrophenylhydrazone of isatin. Journal of Pharmaceutical Science 12:182-184.
16. Reed LJ & Muench M (1938) A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27:493-497.
17. Selvam P, Chandramohan M, De Clercq E, Pannecouque C & Witrouw M (2001) Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3- ylidene) amino]-N (4,6-dimethyl-2-pyrimidinyl) - benzene sulphonamide and its derivatives. European Journal of Pharmaceutical Science 14:313-316.
18. Selvam P, Murugesh N, Chandramohan M & De Clercq E (2004) Pharmacological evaluation of some novel isatin derivatives. Indian Journal of Pharmaceutical Science 66:465-468.
19. Selvam P, Murugesh N, Chandramohan M, Keith KA & Kern ER (2006) Inhibitory activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6- dimethylpyrimidin-2-yl)benzene-sulphonamide and its derivatives against orthopoxvirus replication in vitro. Antiviral Chemistry & Chemotherapy 17:107-110.
20. Sidwell RW, Bailey KW, Bemis PA, Wong M-H, Eisenberg EJ & Huffman JH (1999) Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104. Antiviral Chemistry & Chemotherapy 10:187-193.
21. Sidwell RW & Smee DF (2000) In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Research 48:1-16.
22. Skehel JJ & Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual Review of Biochemistry 69:531-569.
23. Smee DF, Huffman JH, Morrison AC, Barnard DL & Sidwell RW (2001) Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrobial Agents and Chemotherapy 45:743-748.
24. Smee DF, Morrison AC, Barnard DL & Sidwell RW (2002) Comparison of colorimeteric and visual methods for determining anti-influenza (H1N1 and H3N2) viruses activities and toxicities of compounds. Journal of Virological Methods 106:71-79.
25. Smee DF & Sidwell RW (2003) A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Research 57:41-52.
26. Teitz Y & Ronen D (1984) Inhibition of the synthesis of Moloney leukemia virus structural protein by N-Methylisatin-β-4′:4′ diethylthiosemicarbazone. Antimicrobial Agents and Chemotherapy 26:913-916.
27. Teitz Y, Ronen D, Vansover A, Stematsky T & Rigg JL (1994) Inhibition of human immunodeficiency virus by N-methylisatin-β-4′:4′ diethylthiosemicarbazone and N-allyl isatin-β-4′:4′- diallylthiosemicarbazone. Antiviral Research 24:305-314.